BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, June 29, 2026
Home » Topics » Financings

Financings
Financings RSS Feed RSS

Financings for Jan. 25, 2023

Jan. 25, 2023
Biopharmas raising money in public or private financings, including: Atomic, Deciphera, Jasper, Myosana, Oxurion, Precigen, Pliant, Rewind, Verastem.
Read More
Heart scientific overlay

Core Medical completes series C round to develop artificial heart

Jan. 24, 2023
By Doris Yu
Shenzhen Core Medical Technology Co. Ltd. completed a series C round to speed up the development of its left ventricular assist devices (LVAD) for heart failure.
Read More

Financings for Jan. 24, 2023

Jan. 24, 2023
Med-tech firms raising money in public or private financings, including: Endosound, Julier Medical.
Read More

Financings for Jan. 24, 2023

Jan. 24, 2023
Biopharmas raising money in public or private financings, including: Apexigen, Cymabay, Pliant.
Read More

Financings for Jan. 23, 2023

Jan. 23, 2023
Med-tech firms raising money in public or private financings, including: Deciphex, Ferronova, Julier Medical, Renew, Waire Health.
Read More

Financings for Jan. 23, 2023

Jan. 23, 2023
Biopharmas raising money in public or private financings, including: Adarx, Adipopharma, Alvotech.
Read More

Perspectum closes on $36M to commercialize Livermultiscan in US

Jan. 20, 2023
By Nuala Moran
Perspectum Diagnostics Ltd. reported the first close at $36 million of its series C round, with the majority of the new money due to be invested in expanding U.S. uptake of its Livermultiscan diagnostic for assessing and monitoring chronic liver disease.
Read More

Neophore boosts DNA mismatch repair work with series B extension

Jan. 20, 2023
By Nuala Moran
Neophore Ltd. announced a £6 million (US$7.4 million) extension to its series B, bringing the total for the round to £21.5 million and enabling it to take forward a second DNA mismatch repair program.
Read More

Financings for Jan. 20, 2023

Jan. 20, 2023
Med-tech firms raising money in public or private financings, including: Inretio, Therma Bright.
Read More

Financings for Jan. 20, 2023

Jan. 20, 2023
Biopharmas raising money in public or private financings, including: Cadrenal, Deciphera, Endevica, Hemostemix, Mineralys, Windtree.
Read More
Previous 1 2 … 319 320 321 322 323 324 325 326 327 … 680 681 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 26, 2026.
  • Cortec Brain Interchange BCI system

    Brain-computer interfaces are here but long road ahead

    BioWorld
    The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
  • Illustration for mutations in the DNA leading to brain diseases or neurodegenerative disorders

    ENCALS 2026: From genetics to advancing strategies against ALS

    BioWorld Science
    Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
  • Subsense BCI platform

    Next wave of BCI firms builds on pioneers to tackle challenges

    BioWorld
    With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
  • Boehringer Ingelheim identifies new mGlu3 receptor agonists

    BioWorld Science
    Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing